(Q33756737)

29 July 2017

1 reference

title

Social phobia: issues in assessment and management (English)

1 reference

29 July 2017

K M Connor

1

1 reference

29 July 2017

J R Davidson

series ordinal

2

1 reference

29 July 2017

S Sutherland

series ordinal

3

1 reference

29 July 2017

R Weisler

series ordinal

4

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

40 Suppl 6

1 reference

29 July 2017

page(s)

S60-5; discussion S73-4

1 reference

Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

Social phobia. Comorbidity and morbidity in an epidemiologic sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

Moclobemide in Social Phobia: A Pilot Open Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

Discontinuation of clonazepam in the treatment of social phobia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

Sertraline in social phobia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

Sertraline in social phobia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

Imipramine in the treatment of social phobia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

The assessment and treatment of performance anxiety in musicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

The Brief Social Phobia Scale: a psychometric evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

Computerized screening for psychiatric disorders in an outpatient community mental health clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

Prevalence of Body Dysmorphic Disorder in patients with anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1999.TB00935.X

10.1111/J.1528-1157.1999.TB00935.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference